Literature DB >> 18253708

The contribution of growth hormone to mammary neoplasia.

Jo K Perry1, Kumarasamypet M Mohankumar, B Starling Emerald, Hichem C Mertani, Peter E Lobie.   

Abstract

While the effects of growth hormone (GH) on longitudinal growth are well established, the observation that GH contributes to neoplastic progression is more recent. Accumulating literature implicates GH-mediated signal transduction in the development and progression of a wide range malignancies including breast cancer. Recently autocrine human GH been demonstrated to be an orthotopically expressed oncogene for the human mammary gland. This review will highlight recent evidence linking GH and mammary carcinoma and discuss GH-antagonism as a potential therapeutic approach for treatment of breast cancer.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18253708      PMCID： PMC2665193          DOI： 10.1007/s10911-008-9070-z

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN： 1083-3021            Impact factor:   2.673


  143 in total

Review 1.  The oncogenic potential of growth hormone.

Authors:  Jo K Perry; B Starling Emerald; Hichem C Mertani; Peter E Lobie
Journal:  Growth Horm IGF Res       Date:  2006-11-13       Impact factor: 2.372

Review 2.  Does growth hormone cause cancer?

Authors:  P J Jenkins; A Mukherjee; S M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  2006-02       Impact factor: 3.478

3.  Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins.

Authors:  Ellen Lundqvist; Jaakko Kaprio; Pia K Verkasalo; Eero Pukkala; Markku Koskenvuo; Karin C Söderberg; Maria Feychting
Journal:  Int J Cancer       Date:  2007-08-15       Impact factor: 7.396

4.  Cellular expression of growth hormone and prolactin receptors in human breast disorders.

Authors:  H C Mertani; T Garcia-Caballero; A Lambert; F Gérard; C Palayer; J M Boutin; B K Vonderhaar; M J Waters; P E Lobie; G Morel
Journal:  Int J Cancer       Date:  1998-04-17       Impact factor: 7.396

Review 5.  Growth hormone treatment and cancer risk.

Authors:  Indraneel Banerjee; Peter E Clayton
Journal:  Endocrinol Metab Clin North Am       Date:  2007-03       Impact factor: 4.741

6.  Growth hormone-deficient dwarf animals are resistant to dimethylbenzanthracine (DMBA)-induced mammary carcinogenesis.

Authors:  Melinda M Ramsey; Rhonda L Ingram; Adrienne B Cashion; Amy H Ng; J Mark Cline; A F Parlow; William E Sonntag
Journal:  Endocrinology       Date:  2002-10       Impact factor: 4.736

Review 7.  Are trefoil factors oncogenic?

Authors:  Jo K Perry; Nagarajan Kannan; Prudence M Grandison; Murray D Mitchell; Peter E Lobie
Journal:  Trends Endocrinol Metab       Date:  2007-12-03       Impact factor: 12.015

Review 8.  Mechanisms of disease: angiogenesis and the management of breast cancer.

Authors:  Susana Banerjee; Mitch Dowsett; Alan Ashworth; Lesley-Ann Martin
Journal:  Nat Clin Pract Oncol       Date:  2007-09

9.  Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor.

Authors:  Berrin Ergun-Longmire; Ann C Mertens; Pauline Mitby; Jing Qin; Glenn Heller; Weiji Shi; Yutaka Yasui; Leslie L Robison; Charles A Sklar
Journal:  J Clin Endocrinol Metab       Date:  2006-07-05       Impact factor: 6.134

Review 10.  Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis.

Authors:  Mark D Sternlicht
Journal:  Breast Cancer Res       Date:  2005-12-05       Impact factor: 6.466
View more
  30 in total

Review 1.  Extrapituitary production of anterior pituitary hormones: an overview.

Authors:  S Harvey; C Arámburo; E J Sanders
Journal:  Endocrine       Date:  2011-11-15       Impact factor: 3.633

2.  Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.

Authors:  Weijie Zhang; Pengxu Qian; Xiao Zhang; Min Zhang; Hong Wang; Mingming Wu; Xiangjun Kong; Sheng Tan; Keshuo Ding; Jo K Perry; Zhengsheng Wu; Yuan Cao; Peter E Lobie; Tao Zhu
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

Review 3.  Extrapituitary growth hormone.

Authors:  S Harvey
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 4.  Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.

Authors:  Darlene E Berryman; Jens Sandahl Christiansen; Gudmundur Johannsson; Michael O Thorner; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2008-08-16       Impact factor: 2.372

5.  Lactogens and estrogens in breast cancer chemoresistance.

Authors:  Gila Idelman; Eric M Jacobson; Traci R Tuttle; Nira Ben-Jonathan
Journal:  Expert Rev Endocrinol Metab       Date:  2011-05

6.  Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.

Authors:  Erica Gentilin; Mariella Minoia; Marta Bondanelli; Federico Tagliati; Ettore C Degli Uberti; Maria Chiara Zatelli
Journal:  Endocrine       Date:  2016-09-01       Impact factor: 3.633

Review 7.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

8.  Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.

Authors:  Vijay Pandey; Jo K Perry; Kumarasamypet M Mohankumar; Xiang-Jun Kong; Shu-Min Liu; Zheng-Sheng Wu; Murray D Mitchell; Tao Zhu; Peter E Lobie
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

9.  Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.

Authors:  Kristopher C Carver; Timothy M Piazza; Linda A Schuler
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

Review 10.  Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.

Authors:  Stuart J Frank; Serge Y Fuchs
Journal:  Biochim Biophys Acta       Date:  2008-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.